Susquehanna Fundamental Investments, LLC Karyopharm Therapeutics Inc. Transaction History

Susquehanna Fundamental Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.08 - $5.82 $255,179 - $364,006	-62,544 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.21 - $8.61 $425,792 - $703,660	-81,726 Reduced 56.65%	62,544 $402,000
Q3 2021 Nov 15, 2021	BUY	$4.45 - $10.63 $278,320 - $664,842	62,544 Added 76.53%	144,270 $840,000
Q2 2021 Aug 11, 2021	BUY	$8.11 - $11.11 $512,097 - $701,529	63,144 Added 339.81%	81,726 $843,000
Q1 2021 May 17, 2021	BUY	$9.85 - $17.69 $183,032 - $328,715	18,582 New	18,582 $195,000
Q4 2020 Feb 16, 2021	SELL	$14.15 - $17.19 $359,452 - $436,677	-25,403 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$14.14 - $19.71 $359,198 - $500,693	25,403 New	25,403 $371,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $54.3M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.